Markossian TW, et al. - Researchers assessed statin use in 581,344 veterans aged ≥50 years with nondialysis-dependent chronic kidney disease (CKD) Stages 3–5 with no history of kidney transplantation or dialysis, as well as determined the impact of presence of clinical atherosclerotic cardiovascular disease (ASCVD) and diabetes on the statin use. They analyzed pharmacy dispensing records during fiscal years 2012 and 2013 from the US Department of Veterans Affairs Healthcare System in order to ascertain statin use. They also calculated 10-year predicted ASCVD risk. Findings revealed statin use in 62.1% CKD veterans in 2012 and 55.4% used statins continuously over 2 years (2012–13). Overall, findings were suggestive of low statin use in veterans with nondialysis-dependent CKD in the absence of ASCVD or diabetes, however, the predicted ASCVD risk was high.